Catalyze Supports Innovation in Scandinavia and Opens New Office in Copenhagen, Denmark
Amsterdam, February 14, 2018
Catalyze makes successful move with European expansion
Catalyze has opened the doors to their new office in Copenhagen, Denmark. The new office will be at the Copenhagen Bio Science Park (COBIS), close to many companies active in the field of Life Sciences. From this office, Catalyze will be able to better serve its existing and new clients in Medicon Valley and the rest of the Nordics. The office in Copenhagen is the company’s first office expansion outside the Netherlands. Catalyze serves a rapidly increasing number of clients propelled by the success of its projects. Catalyze plans to open more offices to get closer to its customer base.
Catalyze has become a leading consulting firm in non-dilutive funding. Tailored funding plans are designed by our Strategic Funding Unit (SFU) and highly specialized professional grant writers subsequently help our clients apply for these funds. Through our partner network and business matchmaking services, we help clients to initiate ambitious (international) collaborative projects. Expansion in the European market will provide Catalyze with a greater capacity for development of its network, partnerships, and alliances. Moreover, it will provide accessibility, local support and specific focus for current and prospective clients in the Scandinavian region. Catalyze will provide its services to leading researchers and innovators in the life sciences and adjacent industries.
Catalyze Founder & Director, Theodoor Rutgers comments on the expansion of Catalyze to Denmark:
“We are very excited about our European expansion to increase accessibility to our services for our growing number of clients. We have chosen the heart of Medicon Valley as our first location. We see that Medicon Valley forms one of the most promising life science hubs in Europe with tremendous innovation capacity. Strong growth in the Life Science industry has been one of the highlights of the Nordics in the recent years. We are already working with many clients in the Nordics, and through our local office, we will be in the position to offer even better services to our existing and new clients. We are proud to actively engage with the local life science community and Medicon Valley alliances.”
As Quirein te Roller, Commercial Director says:
“We have noticed that our international clients really appreciate the input of our Strategic Funding Unit (SFU), while defining their long-term non-dilutive funding strategy. Furthermore, our unique Matchmaking services throughout Europe are highly appreciated as well, since strong consortia increase the success chances of our clients substantially, while saving time and money for all involved.”
The expansion to Denmark grants the opportunity for further success and influence in the industry while providing clients with the highest quality services and knowledge. This is supported by a solid network built over years. Catalyze maintains successful and long-lasting relationships due to client focus, highly educated and specialized consultants, and a full service offering comparable to few others in the industry.
Finally, the newly appointed country manager, Hamza Deiri has given a statement on his expectations of Catalyze in Denmark and the Scandinavian region:
“We, at Catalyze, are aiming to help our clients to reach their strategic business objectives and accelerate the development of new products and applications in the field of Life Sciences. Our main driver is the contribution to the development of innovations, that structurally advance the healthcare ecosystem.”
Our office is located at Ole Maaløesvej 3, DK 2200 Copenhagen N. Denmark.Our Business Developer in the Nordics: Hamza Deiri, can be reached at +45 2 751 20 40.
Catalyze is a market leader in obtaining funding for biomedical and healthcare innovations, as well as for projects in the related ICT, eHealth and big data fields. Catalyze helps leading researchers and companies secure financing for ambitious R&D projects, from early-stage scientific research up to clinical stage development. Catalyze combines subsidies, loans and venture capital, tailored to the client’s plans and ambitions. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. The company has a strong passion for the latest technological innovations and its top consultants work with the best clients and projects in Europe and beyond. Catalyze has the ambition to further expand internationally from its headquarters in The Netherlands.